Search Results - "Tafesse, B"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Developing Novel Anticancer Drugs for Targeted Populations: An Update by Tafesse, Tadesse B, Bule, Mohammed H, Khan, Fazlullah, Abdollahi, Mohammad, Amini, Mohsen

    Published in Current pharmaceutical design (2021)
    “…Due to higher failure rates, lengthy time and high cost of the traditional de novo drug discovery and development process, the rate of opportunity to get new,…”
    Get more information
    Journal Article
  2. 2

    If Channel as an Emerging Therapeutic Target for Cardiovascular Diseases: A Review of Current Evidence and Controversies by Mengesha, Hayelom G., Tafesse, Tadesse B., Bule, Mohammed H.

    Published in Frontiers in pharmacology (24-11-2017)
    “…In 2015, non-communicable diseases accounted for 39.5 million (70%) of the total 56.4 million deaths that occurred globally, of which 17.7 million (45%) were…”
    Get full text
    Journal Article
  3. 3

    Obstetric fistula in rural Ethiopia by Muleta, M, Fantahun, M, Tafesse, B, Hamlin, E C, Kennedy, R C

    Published in East African medical journal (01-11-2007)
    “…To determine the prevalence of obstetric fistula in rural Ethiopia and identify the circumstances and barriers to care that enhance development of obstetric…”
    Get full text
    Journal Article
  4. 4

    I f Channel as an Emerging Therapeutic Target for Cardiovascular Diseases: A Review of Current Evidence and Controversies by Mengesha, Hayelom G, Tafesse, Tadesse B, Bule, Mohammed H

    Published in Frontiers in pharmacology (24-11-2017)
    “…In 2015, non-communicable diseases accounted for 39.5 million (70%) of the total 56.4 million deaths that occurred globally, of which 17.7 million (45%) were…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Cryptosporidiosis in children seen at the children's clinic of Yekatit 12 Hospital, Addis Ababa by Assefa, T, Mohammed, H, Abebe, A, Abebe, S, Tafesse, B

    Published in Ethiopian medical journal (01-01-1996)
    “…The stools of 214 children under five years of age with diarrhoea were examined for Cryptosporidium oocysts using the Modified Ziehl Nelson Technique. Twelve…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Immunogenicity of hepatitis B vaccine simultaneously administered with the expanded programme on immunisation (EPI) by Tsega, E, Tafesse, B, Nordenfelt, E, Wolde-Hawariat, G, Hansson, B G, Lindberg, J

    Published in Journal of medical virology (01-12-1990)
    “…To assess the immunogenicity of hepatitis B vaccine simultaneously administered with the Expanded Programme on Immunisation (EPI) vaccines, a total of 300…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11

    Immunogenicity, reactogenicity and comparison of two doses of recombinant DNA yeast-derived hepatitis B vaccine in Ethiopian children by Tsega, E, Tafesse, B, Horton, J, Nordenfelt, E, Wolde-Hawariat, G, Hansson, B G, Lindberg, J

    Published in Tropical and geographical medicine (01-01-1991)
    “…Hepatitis B virus infection and its sequelae, chronic hepatitis, cirrhosis of the liver and primary hepatocellular carcinoma (PHC), are important medical…”
    Get more information
    Journal Article
  12. 12

    Seizure Remission and Its Predictors Among Epileptic Patients on Follow-Up at Public Hospitals in Eastern Ethiopia: A Retrospective Cohort Study by Mohammed, Ammas Siraj, Mishore, Kirubel Minsamo, Tafesse, Tadesse Bekele, Jambo, Abera, Husen, Ahmed Mohammed, Alemu, Addisu

    Published in International journal of general medicine (30-11-2023)
    “…Background: Epilepsy is one of the common chronic neurological disorders with varying therapeutic responses. Despite the high prevalence of epilepsy and the…”
    Get full text
    Journal Article
  13. 13

    Efficient Scheduling Algorithms for MpSoC Systems by Tafesse, B., Raina, A., Suseela, J., Muthukumar, V.

    “…MpSoCs have been proposed as a viable solution for present day application, which requires a growing demand in data processing and real-time processing with…”
    Get full text
    Conference Proceeding
  14. 14
  15. 15

    Antibody levels in Ethiopian children five years after vaccination with two different doses of hepatitis B vaccine: is there a need for booster vaccine? by Tsega, E, Horton, J, Nordenfelt, E, Hansson, B J, Tafesse, B, Wolde-Hawariat, G, Lindberg, J

    Published in Canadian journal of gastroenterology (01-01-1998)
    “…It was hypothesized that, following effective initial vaccination, a booster dose of hepatitis B vaccine will not be necessary in areas of hyperendemicity for…”
    Get full text
    Journal Article